Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.39 |
| ▸ | DRD2 | P14416 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | HRH1 | P35367 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23328947 | 0.74 | SLC6A3 (0.48) | SLC6A3DRD2HTR2AHRH1 | |
| SCHEMBL10163704 | 0.72 | SLC6A3 (0.46) | SLC6A3DRD2HTR2AHRH1MEN1 | |
| SCHEMBL848336 | 0.70 | — | — | |
| SCHEMBL9285640 | 0.69 | PIK3CD (0.37) | SLC6A3 | |
| SCHEMBL2819185 | 0.67 | SLC6A3 (0.47) | SLC6A3DRD2HTR2AHRH1MEN1 | |
| SCHEMBL9963728 | 0.67 | — | — | |
| SCHEMBL18938015 | 0.66 | SLC6A3 (0.41) | SLC6A3DRD2HTR2AHRH1 | |
| SCHEMBL21501929 | 0.66 | SLC6A3 (0.42) | SLC6A3DRD2HTR2AHRH1 | |
| SCHEMBL16603147 | 0.66 | SLC6A3 (0.46) | SLC6A3DRD2HTR2AHRH1MEN1 | |
| SCHEMBL348008 | 0.66 | SLC6A3 (0.46) | SLC6A3DRD2HTR2AHRH1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024112830-A1 | INHIBITORS OF SOLUTE CARRIER FAMILY 6A MEMBER 19 (SLC6A19) AND METHODS OF USE THEREOF | MAZE THERAPEUTICS, INC. (US) | 2024-05-30 | — | — | WO | disclosed |